Back
NVIDIA Corp. Vs. Nektar Therapeutics Sector Stock Comparison
Buy
54
NVDA
NVIDIA Corp.
Last Price:
$180.96
Seasonality Move:
16.78%
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$46.82
Seasonality Move:
6.44%
Buy
54
NVIDIA Corp. (NVDA)
is a Buy
Is NVIDIA Corp. a Buy, Sell or Hold?
-
The current NVIDIA Corp. [NVDA] share price is $180.99. The Score for NVDA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
NVDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVDA Stock Price Chart
What is NVIDIA Corp.'s stock price today?
-
The NVIDIA Corp. share price today is $180.99The current trend is relatively stagnant and NVDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $46.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.6 | Sell |
| Relative Strength Index (14 RSI): | 49.63 | Sell |
| Chaikin Money Flow: | 266426543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (176.52 - 185) | Buy |
| Bollinger Bands (100): | (174.5 - 190.2) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.95 | Sell |
| Relative Strength Index (14 RSI): | 38.83 | Sell |
| Chaikin Money Flow: | 857593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.69 - 61.39) | Sell |
| Bollinger Bands (100): | (34.99 - 62.73) | Sell |
NVDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 177.48 | Buy |
| 20-day SMA: | 179.68 | Buy |
| 50-day SMA: | 185.65 | Sell |
| 200-day SMA: | 157.56 | Buy |
| 8-day EMA: | 177.73 | Buy |
| 20-day EMA: | 180.24 | Buy |
| 50-day EMA: | 182.39 | Sell |
| 200-day EMA: | 164.41 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.29 | Sell |
| 20-day SMA: | 55.51 | Sell |
| 50-day SMA: | 57.37 | Sell |
| 200-day SMA: | 31.53 | Buy |
| 8-day EMA: | 49.58 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 54.29 | Sell |
| 200-day EMA: | 38.34 | Buy |
NVIDIA Corp. Earnings Growth & NVDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.26 per share, an increase next quarter of $0.20 per share, an increase this year of $1.72 per share, and an increase next year of $1.74 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
NVIDIA Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||